QUILLICHEW
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 03 Jan 2023)
What this means for you
Registered since 03 Jan 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86690748
- Registration number
- 5115386
- Mark type
- Stylized text
- Filed
- 13 Jul 2015
- Published for opposition
- 01 Dec 2015
- Registered
- 03 Jan 2017
- Attorney of record
- Cathy A. Kodroff
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of central nervous system diseases and disorders; Pharmaceutical preparations for the treatment of attention deficit hyperactivity disorder
Owner
- NextWave Pharmaceuticals, Inc., Monmouth Junction, NJ, US
- NextWave Pharmaceuticals, Inc., New York, NY, US
- NextWave Pharmaceuticals, Inc., New York, NY, US
Prosecution history
- 07 Mar 2026 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 03 Jan 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 03 Jan 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 03 Jan 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 17 Jun 2022 — TEAS SECTION 8 & 15 RECEIVED
- 03 Jan 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 05 Feb 2019 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 05 Feb 2019 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 03 Oct 2018 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 03 Jan 2017 — REGISTERED-PRINCIPAL REGISTER
- 01 Dec 2016 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 30 Nov 2016 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 30 Nov 2016 — STATEMENT OF USE PROCESSING COMPLETE
- 09 Nov 2016 — USE AMENDMENT FILED
- 28 Nov 2016 — CASE ASSIGNED TO INTENT TO USE PARALEGAL